Infectious diseases continue to be a leading cause of death worldwide, particularly in low-income countries and especially in young children. Globally they account for around 14% of deaths.
The most recent emergence of an infectious disease having a global impact was the COVD-19 pandemic, accounting for in excess of 14 million premature deaths.
The majority of agents that cause disease in humans are viruses or bacteria and there is a critical need for rapid diagnosis of patients, particularly children in order to select the most appropriate primary therapy and to avoid over-use of antibiotics.
In addition to providing unique laboratory assays to enable the detection and characterisation of emergent or hospital-acquired infections, EDX Medical is developing an innovative multiplex ‘Point of Care’ testing system which rapidly provides a laboratory-grade solution at the bedside to differentiate bacterial from viral infection and provide detailed information on a number of life-threatening diseases such as sepsis.
